NCT01113138已完成不适用
Pharmacokinetic Study of Mablet as Oral Supplement and Magnesium Sulfate as Infusion
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Pharmacokinetic parameters
研究概览
简要总结
The present study is part of a project titled 'Magnesium in asthma and chronic obstructive pulmonary disease'. The hypothesis of the main project is that daily magnesium supplement will benefit patients with asthma and chronic obstructive pulmonary disease.
The aim of this part of the project is to study the pharmacokinetics of the following two magnesium supplements:
- Mablet (dietary supplement)
- Magnesium Sulfate (solution for infusion)
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healthy volunteers.
排除标准
- •Using pharmaceuticals/supplements,
- •Vegans/vegetarians,
- •Major changes in eating habits within one week prior to study start.
研究组 & 干预措施
Mablet
Active Comparator
干预措施: Mablet (Magnesium-supplement) (Dietary Supplement)
Magnesium sulfate
Active Comparator
干预措施: Magnesium Sulfate (Drug)
结局指标
主要结局
Pharmacokinetic parameters
时间窗: Two years
Clearance, half-life \& absorption fraction
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Bronchial Challenge Test of Magnesium-treated AsthmaticsAsthmaNCT01118923University of Aarhus12
已完成
不适用
Daily Magnesium-supplement for Severe AsthmaticsAsthmaNCT01113151University of Aarhus5
Unknown
2 期
Efficacy of Oral Supplementation With Magnesium to Reduce Febrile NeutropeniaFebrile NeutropeniaNCT03449693Universidad Nacional Autonoma de Mexico214
尚未招募
4 期
To study the effect of oral magnesium supplementation on Blood pressure and lipid profile in patients during initial stage of hypertensioCTRI/2023/08/056417Government medical college, Patial
进行中（未招募）
2 期
Oral Intake of Mg in Controlled Asthmatic PatientsBronchial AsthmaNCT06721247Zagazig University166